MSB 2.17% $1.13 mesoblast limited

Ann: Confirmatory Phase 3 Back Pain Trial Actively Enrols, page-35

  1. 6,999 Posts.
    lightbulb Created with Sketch. 1291
    https://hotcopper.com.au/data/attachments/6328/6328399-55c80600211bfabfa03473d87d6133d2.jpg


    https://hotcopper.com.au/data/attachments/6328/6328386-92935301a9965e59aedc12019653333d.jpg
    The company is in a worse position now than in 2018. Growing up is an understatement.

    What are you seeing here that you think these people are able to go it alone? Tying their own shoelaces isn't a given!

    You're acting like these people are hitting everything out of the park?! They have never been at bat?!





    Do you see SI 'indicating' that a partner is needed for adult label extension for GVHD, in the above? I suspect that 3D is needed for it - SI mentioned it at the last AGM - I've provided the link and time position previously. 3D means partnership, IMO.

    Mesoblast is way out of their depth, IMO. And running out of cash. Why isn't Grunenthal partnering for CLBP in the USA?
    Last edited by Pledge: Monday, 15:29
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.